BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Soulières D, Mercier-ross J, Fradette C, Rozova A, Tsang YC, Tricta F. The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease. Ann Hematol. [DOI: 10.1007/s00277-021-04728-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kontoghiorghes GJ. Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology. Int J Mol Sci 2022;23:6735. [PMID: 35743183 DOI: 10.3390/ijms23126735] [Reference Citation Analysis]